Source: Clinical breast cancer. Unidade: FM
Subjects: ADENOCARCINOMA, MAMA, METÁSTASE NEOPLÁSICA, BIÓPSIA, MODELO MÉDICO, PREDIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARIA, Maira Teixeira et al. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature. Clinical breast cancer, v. 18, n. 5, p. E805-E812, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.clbc.2018.04.011. Acesso em: 16 nov. 2024.APA
Daria, M. T., Maesaka, J. Y., Azevedo Neto, R. S. de, Barros, N. de, Baracat, E. C., & Filassi, J. R. (2018). Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature. Clinical breast cancer, 18( 5), E805-E812. doi:10.1016/j.clbc.2018.04.011NLM
Daria MT, Maesaka JY, Azevedo Neto RS de, Barros N de, Baracat EC, Filassi JR. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature [Internet]. Clinical breast cancer. 2018 ; 18( 5): E805-E812.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.clbc.2018.04.011Vancouver
Daria MT, Maesaka JY, Azevedo Neto RS de, Barros N de, Baracat EC, Filassi JR. Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy-Original Study and Critical Evaluation of the Literature [Internet]. Clinical breast cancer. 2018 ; 18( 5): E805-E812.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.clbc.2018.04.011
